May 27, 2026 Summary: A survey finds that 35% of adults who tried GLP-1 medications stopped taking them, most commonly due to reaching their target weight, experiencing side effects, or lacking affordable coverage each posing distinct challenges for employers designing benefits
High-Risk Scenarios and Safety Monitoring Although GLP-1 medications are generally well-tolerated, certain risks require careful management
In a mouse study from the University of Utah , animals treated with semaglutide lost about 10% of lean mass overall with skeletal muscle itself decreasing by about 6% , and muscle strength declining disproportionately to size ( University of Utah Health )
The Arizona Republic
Our team offers easy-to-follow, personalized plans backed by experienced care
Talk with your doctor about whether antidepressants are safe for you to take during your treatment with Ozempic